Fundraising Fox

Lalo Flores

Investor

Venture Partner at Scion Life Sciences

Doylestown, Pennsylvania, United States

About

Lalo Flores is a Venture Partner at Scion Life Sciences and CEO of Flux Therapeutics, a Scion portfolio company. He has over 30 years of experience in the biopharmaceutical industry, beginning at Tularik (later acquired by Amgen) and holding senior R&D leadership roles at Merck and Johnson & Johnson. He co-founded Novira Therapeutics (acquired by Johnson & Johnson in 2015) and was founding CEO of Century Therapeutics, which he took public in 2021. He holds a doctorate in Biochemistry and Molecular Biology from Rutgers University and completed post-doctoral work at the Salk Institute.

Invests in

Biotech

Experience

  1. Stealth StartupChief Executive Officercurrent2023 — presentCambridge, Massachusetts, United States
  2. Century TherapeuticsChief Executive Officer2018 — 2023Greater Philadelphia Area
  3. Johnson & JohnsonEntrepreneur in Residence2018Spring House, PA
  4. Johnson & JohnsonVice President of R&D2015 — 2018Spring House, PA
  5. Novira TherapeuticsCo-founder, President and Chief Scientific Officer2009 — 2015Doylestown, PA
  6. MerckSenior Director2004 — 2008
  7. MerckDirector Antiviral Research1999 — 2004
  8. TularikScientist1992 — 1999
  9. The Salk InstitutePost Doctoral Fellow1991 — 1992

Education

  1. Rutgers UniversityPhD, Biochemistry
  2. Pontificia Universidad Católica de ValparaísoBS, Biology

Skills & more

Therapeutic Areas11HCV4Lifesciences5Immunology6Endocrinology14Drug Discovery28Target Identification6Clinical Research10Drug Development12Osteoporosis5Biotechnology20

Languages Spanish

From Lalo's professional profile.

Same school

Shared employers

Colleagues at Scion Life Sciences